Academic Journal
Q1Pharmacological Research
About Pharmacological Research
Pharmacological Research is a scholarly journal published by Academic Press. SCImago 2025 lists it in Q1, with an SJR of 2.909 and H-index of 200.
Coverage: 1989-2026. Research categories: Pharmacology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Three-dimensional cell culture models in oncology: From tumour spheroids to integrated microphysiological systems
Eva Martin, Flavien Bessaguet, Nicolas Clere
2026-11 · DOI: 10.1016/j.phrs.2026.108465Gut microbiota modulates nonalcoholic fatty liver disease (NAFLD) progression via regulation of gluconeogenesis: mechanisms and translational research
WeiZhou Wang, YunTao Tang, ZiQian Wan, ZhiQuan Zhang et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108444Targeting bone marrow mesenchymal stem cells with traditional Chinese medicine active ingredients: Restoring hematopoietic microenvironment homeostasis to prevent and treat myelosuppression
Jingnan Yan, Yafeng Qi, Jiajun Guo, Xiaodan Jiang et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108460Sinomenine modulates an MGAT3-associated B-cell IgG N-glycosylation pathway linked to macrophage FcγRIII/CD16-related signaling in rheumatoid arthritis
Peiyu Liu, Jingtao Zhang, Jingrong Wang, Runze Li et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108458Pharmacological intersections between type 2 diabetes and cancer: Metabolic crosstalk, antidiabetic therapies and clinical implications
Dequan Liu, Deqian Xie, Xiangyu Che, Xiaorui Li et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108456GPR75: A dual-ligand receptor for 20-HETE and CCL5 with emerging roles in central and peripheral regulation of metabolic diseases
Yu-Ning Hou, Shu-Jing Liu, Liang-Ming Li
2026-11 · DOI: 10.1016/j.phrs.2026.108452Spatiotemporal redistribution of HMGB1 shapes organelle interactome dysfunction and informs precision pharmacological targeting in diabetic vascular disease
Yang Chen, Juan Xiao, Hai-bo Si
2026-11 · DOI: 10.1016/j.phrs.2026.108467Nanomedicine-based targeted strategies for metabolic dysfunction-associated steatotic liver disease: Unraveling pathogenic crosstalk and overcoming clinical barriers
Mingyue Zhou, Jinhai Huo, Wei Wang, Enhui Lai et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108471Cellular senescence of fibro-adipogenic progenitors by STAT5A/GFPT2/O-GlcNAcylation impairs muscle recovery after glucocorticoid-induced injury
Bingfei Li, Wei Xiang, Wanwan Qi, Xinxin Liu et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108461Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl2 on oxaliplatin-triggered immunogenic cell death in pancreatic cancer
Zhimiao Zou, Xia Li, Yan Ma, Yiyun Huang et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108459Reconfiguring the macrophage-centric intercellular network in pulmonary fibrosis: Emerging perspectives and therapeutic opportunities
Yujie Yang, Senyu Liu, Shangxuan Wang, Aoxin Zhang et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108437NMN mitigates LPS-induced liver injury by inhibiting ferroptosis via suppression of the cGAS-STING-ACSL4 axis
Yan Liao, Cheng-long Zhu, Wang-zhe-qi Zhang, Lin-dong Cheng et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108454Druggable tumor-nerve-immune circuits in cancer pain: Model systems, human translatability and therapeutic paradoxes
Yue Hu, Lingxuan Hou, Xiaobei Zhang, Huizhong Jiang et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108445Geroprotective potential of anti-diabetic medications: Bridging type 2 diabetes and accelerated aging
Haoling Cui, Ayesha Nisar, Zhongping Duan, Jian Mao et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108443Neural remodeling shapes a nerve-dependent metastatic ecosystem in ovarian cancer
Li Ou, Chenzhao Feng, Chen Sun, Zeping Xue et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108463Kaempferol attenuates type 2 diabetic osteoporosis via METTL3/YTHDF2-regulated PTEN m⁶A methylation and ferritinophagy-ferroptosis inhibition
Bingwu Huang, Jianpeng Chen, Jiaxu Jia, Han Lin et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108473Potential contribution of the microbiota–gut–brain axis to doxorubicin-associated cognitive impairment: Mechanisms, evidence, and therapeutic opportunities
Mohamed Madkoor, Ruba Ahmed, Rana Hany, Mohamed Abdelnaby et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108455Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC
Yueyue Li, Jingjing Ma, Weitong Peng, Zhengxiang Lv et al.
2026-11 · DOI: 10.1016/j.phrs.2026.108448Race, ethnic and socioeconomic influences on clinical pharmacology. A reflection from the IUPHAR World Smart Medication Day 2026
M.I. Lucena, P. Galappatthy, K. Allegaert, N.A. Buckley et al.
2026-10 · DOI: 10.1016/j.phrs.2026.108400Mitochondrial-centric regulatory networks in MASLD: Integrating quality control, organelle interactions, and gut-liver communication
Jingwen Liu, Kewei Li, Ying Deng, Xi Li et al.
2026-10 · DOI: 10.1016/j.phrs.2026.108410Reviews
Community Reviews
Version History
September 16, 2026 at 2:15 am
September 16, 2026